Proteomic analysis of subcellular changes during apoptosis. This project aims to use a novel proteomic approach to examine mechanisms of apoptosis at the level of the plasma membrane, mitochondrion, nucleus and cytosol, screening protein extracts of cell organelles by the new technique of SELDI-TOF mass spectrometry in which proteins are adsorbed onto activated chips. This will provide protein mass profiles characteristic of various stages of apoptosis, and will allow identification of proteins ....Proteomic analysis of subcellular changes during apoptosis. This project aims to use a novel proteomic approach to examine mechanisms of apoptosis at the level of the plasma membrane, mitochondrion, nucleus and cytosol, screening protein extracts of cell organelles by the new technique of SELDI-TOF mass spectrometry in which proteins are adsorbed onto activated chips. This will provide protein mass profiles characteristic of various stages of apoptosis, and will allow identification of proteins of interest by conventional proteomic methods. The establishment of SELDI-MS as a viable tool for cell proteomics would open new opportunities to understand a broad range of cellular functions at the level of protein expression.Read moreRead less
Structural neurobiology - developing a new capability in Australia to treat mental illness. Mental illness encompasses a multitude of devastating conditions that present a major burden to the Australian economy. In this project powerful tools for determining the three-dimensional shapes and functions of proteins will be utilised to gain new knowledge about the molecular bases of various mental illnesses. The project will involve extensive use of the Australian Synchrotron Facility that is due to ....Structural neurobiology - developing a new capability in Australia to treat mental illness. Mental illness encompasses a multitude of devastating conditions that present a major burden to the Australian economy. In this project powerful tools for determining the three-dimensional shapes and functions of proteins will be utilised to gain new knowledge about the molecular bases of various mental illnesses. The project will involve extensive use of the Australian Synchrotron Facility that is due to open in 2007. This knowledge gained from the project will be used to develop new therapeutic drugs to ameliorate or combat mental diseases in partnership with the Australian Biotechnology Industry.Read moreRead less
New methods to complete the lipidomics puzzle: revealing the structural diversity of lipids by mass spectrometry. Lipid-related disorders such as obesity, diabetes and heart disease are reaching epidemic proportions in the western world. The integration of innovative techniques will provide Australia with unique capabilities to investigate these diseases and place Australia at the forefront of lipid research internationally.
Innovative Approaches to Membrane Protein Crystallography & Drug Discovery. Membrane proteins make up around 30% of the predicted products from our human genome, are critical for life, and represent the targets of biological agents like hormones and toxins as well as most drugs. Yet these proteins have persistently defied our best efforts to study them: we know very little about what they do or what they look like. This project is aimed at cracking the problem of membrane proteins, while at the ....Innovative Approaches to Membrane Protein Crystallography & Drug Discovery. Membrane proteins make up around 30% of the predicted products from our human genome, are critical for life, and represent the targets of biological agents like hormones and toxins as well as most drugs. Yet these proteins have persistently defied our best efforts to study them: we know very little about what they do or what they look like. This project is aimed at cracking the problem of membrane proteins, while at the same time developing screening methods that can be used to design drugs against them. The long-term benefits to the community will include fundamental new knowledge and the development of new technologies and pharmaceuticals.Read moreRead less